Comparative Study of Cardiac Adrenergic Function Explored by I-123-MIBG and CZT Camera (D-SPECT) Versus Anger Camera in Patients With Heart Failure
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 45
- 试验地点
- 1
- 主要终点
- SRSI (summed rest score innervation)
研究概览
简要总结
Cardiological examination constitute one of the major directions in nuclear medicine for detection of myocardial ischemia in patients suspected of coronary disease. In Caen, they constitute 20% of the activity of nuclear medicine. Systolic heart failure (HF) ischemic or nonischemic origin represents a new area of activity of the nuclear cardiology. This is HF stratification study based on cardiac adrenergic function after injection of a tracer: I-123-MIBG. The team Caen nuclear cardiology is one of two teams recognized internationally in the field of evaluating the cardiac sympathetic innervation in cardiomyopathies. Numerous publications from 1992 to the present day have reported encouraging results for the daily use of this tracer in the evaluation of patients with LV dysfunction IC. Recently, interest in using the MIBG has been shown as a prognostic marker of HF in a prospective study of 961 patients. Typically, the camera used was an Anger camera with collimating Nai standard called parallel holes.
The main objective is to validate the measurements of cardiac adrenergic function evaluated by cardiopulmonary mediastinal reports and sympathetic innervation scores VG after injection of I-123-MIBG in 80 patients with heart failure.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age above 18 years (except major patients under guardianship)
- •patient who signed the consent form
- •written and spoken French
- •Beneficiaries of the social security system
- •Stable heart failure with LV dysfunction (<45%) of ischemic or nonischemic origin
排除标准
- •Patients with a recent history (<21 days) acute coronary failure (myocardial infarction, unstable angina)
- •Patients with severe extra-cardiac disease may interfere with treatment decisions (cancer, severe hepatic or renal impairment)
- •Major patients under guardianship
- •Pregnant or lactating women
- •Women in age and condition of childbearing
- •Patients unable to understand the purpose of the study
研究组 & 干预措施
Adrenergic Function Explorations with CZT camera
I-123-MIBG and CZT Camera (D-SPECT)
干预措施: I-123-MIBG (Drug)
Adrenergic Function Explorations with CZT camera
I-123-MIBG and CZT Camera (D-SPECT)
干预措施: CZT Camera (D-SPECT) (Device)
Adrenergic Function Explorations with Anger camera
I-123-MIBG and Anger Camera
干预措施: I-123-MIBG (Drug)
Adrenergic Function Explorations with Anger camera
I-123-MIBG and Anger Camera
干预措施: Anger Camera (Device)
结局指标
主要结局
SRSI (summed rest score innervation)
时间窗: 4 hours after I-123-MIBG perfusion
with CZT camera and Anger camera
SRS (summed rest score)
时间窗: 4 hours after I-123-MIBG perfusion
with CZT camera and Anger camera
次要结局
未报告次要终点
